March 14 | 2022 2cureX launches IndiTreat® mCRC Explore and completes portfolio rollout plan for 2022 Read more
February 24 | 2022 2cureX publishes interim report for the fourth quarter and all 12 months of 2021 Read more
February 24 | 2022 2cureX offentliggör delårsrapport för det fjärda kvartalen och alla tolv månader 2021 Read more
February 23 | 2022 2cureX holds a virtual live-session on the 25th of February 2022 to present and discuss the Interim report for the fourth quarter of 2021. Read more
January 11 | 2022 IndiTreat® to be distributed in Czech Republic and Slovakia through Promedica Read more
December 9 | 2021 2cureX signs yet another distribution agreement – this time with Omnigen Medical Products in Turkey Read more
November 29 | 2021 EU publishes an article about the successful finalization of 2cureX’s MicroCaT project. Read more
November 25 | 2021 2cureX offentliggör delårsrapport för det tredje kvartalet och första nio månader 2021 Read more
November 25 | 2021 2cureX publishes interim report for the third quarter and first nine months of 2021 Read more
November 24 | 2021 2cureX expands its Clinical Advisory Board with Professor Andrew Beggs, Queen Elizabeth Hospital Birmingham, UK Read more
November 23 | 2021 2cureX holds a virtual live-session on the 26th of November 2021 to present and discuss the Interim report for the third quarter of 2021. Read more